Ishwaria Subbiah: Does the word “mindfulness” trigger an eye roll?
Ishwaria Subbiah, Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute, shared a post on LinkedIn about a recent paper by Elizabeth Hoge et al. published in JAMA Psychiatry.
“Does the word ‘mindfulness’ trigger an eye roll?
This 2022 randomized clinical trial found that a Mindfulness-Based Stress Reduction (MBSR) program was just as good for managing anxiety disorders as a commonly prescribed pill.
- Personal wellness is a core component of professional wellbeing. Here are a few more key findings:
- This RCT found that a standardized evidence-based MBSR intervention was noninferior to escitalopram for the treatment of anxiety disorders.
- Study-related adverse events occurred for nearly 80% of participants randomized to escitalopram compared to 15% of patients receiving MBSR.”
Authors: Elizabeth Hoge, Eric Bui, Mihriye Mete,
More posts featuring Ishwaria Subbiah.
Ishwaria Subbiah is the Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute (SCRI). She is also the medical director of supportive care oncology, health equity and professional well being at The US Oncology Network.
Dr. Subbiah focuses on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over more than 1,300 physicians at over 250 locations in 24 states across the US. Dr. Subbiah is a globally recognized expert in geriatric oncology, symptom management, palliative care, and healthcare professional well-being.
She previously was an associate professor in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center. She is the Chair for the ASCO Women in Oncology working group and the ASCO State of Cancer Care in America initiative.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023